Related Experiment Video

Updated: Aug 14, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

The potential role of statins in contrast nephropathy

N Attallah1, L Yassine, J Musial

  • 1Division of Nephrology and Hypertension, Department of Medicine CFP-5, Henry Ford Hospital, 2799 West Grand Blvd., Detroit, MI 48202, USA. Nattall1@Hfhs.Org

Clinical Nephrology
|November 5, 2004
PubMed

Insights

Administering statins before cardiac catheterization may reduce the incidence of contrast-induced nephropathy (CN). This study found statin use was associated with better renal function and fewer cases of acute renal failure post-procedure.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Contrast agents can acutely reduce renal function, leading to contrast-induced nephropathy (CN).
  • Preexisting renal dysfunction, diabetes, and low arterial volume are risk factors for CN.
  • Statins, known to reduce oxygen radicals, were investigated for their potential to mitigate CN.

Purpose of the Study:

  • To retrospectively evaluate if prophylactic statin administration before cardiac catheterization decreases the incidence of CN.
  • To assess the impact of statins on renal function and acute renal failure following contrast exposure.

Main Methods:

  • A retrospective study of 1,002 patients undergoing cardiac catheterization.
  • Patients with baseline serum creatinine (SCr) ≥ 1.5 mg/dl were included; none were on statins prior to admission.
  • 250 patients received statins before the procedure, while 752 did not; SCr was monitored for 7 days post-procedure.

Main Results:

  • The statin group showed significantly better post-catheterization SCr levels (2.26 vs 3.1 mg/dl).
  • Patients receiving statins had a shorter hospital stay (2.72 vs 3.32 days) and a lower incidence of acute renal failure (17.2% vs 22.3%).
  • Dialysis requirements and 28-day survival rates were similar between the statin and non-statin groups.

Conclusions:

  • Prophylactic statin administration, combined with hydration, may reduce contrast-induced nephropathy from nonionic, low-osmolality contrast agents.
  • Statins show promise in protecting renal function in patients undergoing procedures requiring contrast media.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...